TY - JOUR
AU - Mikami,, Yuzuru
AB - Abstract The new fluoroquinolone grepafloxacin exhibited MIC90s of 0.6 to 20 mg/L against 134 pathogenic Nocardia spp including Nocardia asteroides sensu stricto, Nocardia farcinica, Nocardia nova, Nocardia brasiliensis, Nocardia otitidiscaviarum and Nocardia transvalensis and was 2–20 times more active in vitro than norfloxacin, ofloxacin, tosufloxacin and ciprofloxacin against these bacteria. This content is only available as a PDF. © The British Society for Antimicrobial Chemotherapy
TI - In-vitro antimicrobial activity of the new fluoroquinolone, grepafloxacin, against pathogenic Nocardia spp.
JF - Journal of Antimicrobial Chemotherapy
DO - 10.1093/jac/35.4.541
DA - 1995-04-01
UR - https://www.deepdyve.com/lp/oxford-university-press/in-vitro-antimicrobial-activity-of-the-new-fluoroquinolone-0WY9lxIGy9
SP - 541
EP - 544
VL - 35
IS - 4
DP - DeepDyve
ER -